首页> 外文OA文献 >Increased antitumour activity and extravasation of immune checkpoint inhibitor due to hyaluronidase expressed from oncolytic adenovirus VCN-01 and generation of new viruses with improved hyaluronidase activity

【2h】

Increased antitumour activity and extravasation of immune checkpoint inhibitor due to hyaluronidase expressed from oncolytic adenovirus VCN-01 and generation of new viruses with improved hyaluronidase activity

机译：由于从葡萄酒腺病毒VCN-01表达的透明质酸酶以及具有改善的透明质酸酶活性的新病毒，增加了抗肿瘤活性和免疫检查点抑制剂的渗透

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
M. Farrera; A. Mato-Berciano; S. Morgado; R. Moreno; J. de Sostoa Pomes; R. Alemany; M. Bazan-Peregrino;
展开▼
作者单位

展开▼
年度 2018
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. First-in-human dose-escalation study of VCN-01, a selective oncolytic adenovirus with hyaluronidase activity in patients with advanced or metastatic cancer [J] . Hidalgo M., Gil M., Garcia-Carbonero R., European journal of cancer: official journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR) . 2016,第Null期

机译：VCN-01（具有透明质酸酶活性的选择性溶瘤腺病毒）在人中的首次剂量递增研究
2. First-in-human dose-escalation study of VCN-01, a selective oncolytic adenovirus with hyaluronidase activity in patients with advanced or metastatic cancer [J] . Hidalgo M., Gil M., Garcia-Carbonero R., European journal of cancer: official journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR) . 2016,第Null期

机译：VCN-01的第一人体剂量升级研究，一种具有晚期或转移性癌症患者透明质酸酶活性的选择性糖尿病腺病毒
3. Safety and Efficacy of VCN-01, an Oncolytic Adenovirus Combining Fiber HSG-Binding Domain Replacement with RGD and Hyaluronidase Expression [J] . Rodriguez-Garcia Alba, Gimenez-Alejandre Marta, Rojas Juan J., Clinical cancer research: an official journal of the American Association for Cancer Research . 2015,第6期

机译：VCN-01的安全性和有效性，一种溶瘤腺病毒，将纤维HSG结合域置换与RGD和透明质酸酶表达相结合
4. Evidence of Anti-tumoral Efficacy in an Immune Competent Setting with an iRGD-Modified Hyaluronidase-Armed Oncolytic Adenovirus [O] . Ahmed Abdullah Al-Zaher, Rafael Moreno, Carlos Alberto Fajardo, 2018

机译：iRGD修饰的透明质酸酶武装溶瘤腺病毒在免疫能力强的环境中抗肿瘤功效的证据。
5. Safety and Efficacy of VCN-01, an Oncolytic Adenovirus Combining Fiber HSG-Binding Domain Replacement with RGD and Hyaluronidase Expression [O] . Alba Rodríguez-García, Marta Giménez-Alejandre, Juan J. Rojas, 2014

机译：VCN-01的安全性和有效性，一种与RGD和透明质酸酶表达替代纤维HSG结合结构域的糖尿病腺病毒

Increased antitumour activity and extravasation of immune checkpoint inhibitor due to hyaluronidase expressed from oncolytic adenovirus VCN-01 and generation of new viruses with improved hyaluronidase activity

著录项

引文网络

相似文献

相关主题

期刊订阅